SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001230439-24-000030
Filing Date
2024-06-14
Accepted
2024-06-14 17:37:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3315
2 poa.pdf EX-99 80086
  Complete submission text file 0001230439-24-000030.txt   115134
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Subject) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39219 | Film No.: 241046184
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ERASCA, INC. 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address